<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-04980710</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-15T23:30:13+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">In Vitro Bactericidal Activity of a Neomycin-Polymyxin B-Nystatin Combination Compared to Metronidazole and Clindamycin Against the Main Bacteria Involved in Bacterial Vaginosis and Aerobic Vaginitis</title>
            <author role="aut">
              <persName>
                <forename type="first">Catherine</forename>
                <surname>Feuillolay</surname>
              </persName>
              <idno type="halauthorid">1496737-0</idno>
              <affiliation ref="#struct-302908"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Sylvie</forename>
                <surname>Salvatico</surname>
              </persName>
              <idno type="halauthorid">1533215-0</idno>
              <affiliation ref="#struct-302908"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Julie</forename>
                <surname>Escola</surname>
              </persName>
              <idno type="halauthorid">3439755-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Barbara</forename>
                <surname>Quioc-Salomon</surname>
              </persName>
              <idno type="idhal" notation="numeric">1516951</idno>
              <idno type="halauthorid" notation="string">2162141-1516951</idno>
              <idno type="ORCID">https://orcid.org/0009-0001-4285-0519</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Frédéric</forename>
                <surname>Carrois</surname>
              </persName>
              <idno type="halauthorid">3439756-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">Christine</forename>
                <surname>Roques</surname>
              </persName>
              <idno type="idhal" notation="numeric">1388215</idno>
              <idno type="halauthorid" notation="string">1552705-1388215</idno>
              <idno type="ORCID">https://orcid.org/0000-0002-7505-1000</idno>
              <affiliation ref="#struct-448187"/>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Équipe</forename>
                <surname>HAL UVSQ</surname>
              </persName>
              <email type="md5">5808107ddbade13399d417929c0cb718</email>
              <email type="domain">uvsq.fr</email>
            </editor>
            <funder>This research was sponsored by Laboratoire Innotech International.</funder>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2025-04-09 15:45:17</date>
              <date type="whenModified">2025-09-23 14:22:15</date>
              <date type="whenReleased">2025-04-09 15:52:22</date>
              <date type="whenProduced">2025</date>
              <date type="whenEndEmbargoed">2025-04-09</date>
              <ref type="file" target="https://hal.science/hal-04980710v1/document">
                <date notBefore="2025-04-09"/>
              </ref>
              <ref type="file" subtype="greenPublisher" n="1" target="https://hal.science/hal-04980710v1/file/pharmaceuticals-18-00340.pdf" id="file-5027440-4355210">
                <date notBefore="2025-04-09"/>
              </ref>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="751146">
                <persName>
                  <forename>Équipe</forename>
                  <surname>HAL UVSQ</surname>
                </persName>
                <email type="md5">5808107ddbade13399d417929c0cb718</email>
                <email type="domain">uvsq.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-04980710</idno>
            <idno type="halUri">https://hal.science/hal-04980710</idno>
            <idno type="halBibtex">feuillolay:hal-04980710</idno>
            <idno type="halRefHtml">&lt;i&gt;Pharmaceuticals&lt;/i&gt;, 2025, 18 (3), pp.340-340. &lt;a target="_blank" href="https://dx.doi.org/10.3390/ph18030340"&gt;&amp;#x27E8;10.3390/ph18030340&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">Pharmaceuticals, 2025, 18 (3), pp.340-340. &amp;#x27E8;10.3390/ph18030340&amp;#x27E9;</idno>
            <availability status="restricted">
              <licence target="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0 - Attribution<ref corresp="#file-5027440-4355210"/></licence>
            </availability>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="TOULOUSE-INP">Toulouse - INP</idno>
            <idno type="stamp" n="UT3-INP">Université de Toulouse / Toulouse INP</idno>
            <idno type="stamp" n="UT3-TOULOUSEINP">Université de Toulouse / Toulouse INP</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">In Vitro Bactericidal Activity of a Neomycin-Polymyxin B-Nystatin Combination Compared to Metronidazole and Clindamycin Against the Main Bacteria Involved in Bacterial Vaginosis and Aerobic Vaginitis</title>
                <author role="aut">
                  <persName>
                    <forename type="first">Catherine</forename>
                    <surname>Feuillolay</surname>
                  </persName>
                  <idno type="halauthorid">1496737-0</idno>
                  <affiliation ref="#struct-302908"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Sylvie</forename>
                    <surname>Salvatico</surname>
                  </persName>
                  <idno type="halauthorid">1533215-0</idno>
                  <affiliation ref="#struct-302908"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Julie</forename>
                    <surname>Escola</surname>
                  </persName>
                  <idno type="halauthorid">3439755-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Barbara</forename>
                    <surname>Quioc-Salomon</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">1516951</idno>
                  <idno type="halauthorid" notation="string">2162141-1516951</idno>
                  <idno type="ORCID">https://orcid.org/0009-0001-4285-0519</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Frédéric</forename>
                    <surname>Carrois</surname>
                  </persName>
                  <idno type="halauthorid">3439756-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">Christine</forename>
                    <surname>Roques</surname>
                  </persName>
                  <idno type="idhal" notation="numeric">1388215</idno>
                  <idno type="halauthorid" notation="string">1552705-1388215</idno>
                  <idno type="ORCID">https://orcid.org/0000-0002-7505-1000</idno>
                  <affiliation ref="#struct-448187"/>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">103477</idno>
                <idno type="issn">1424-8247</idno>
                <title level="j">Pharmaceuticals</title>
                <imprint>
                  <publisher>MDPI</publisher>
                  <biblScope unit="volume">18</biblScope>
                  <biblScope unit="issue">3</biblScope>
                  <biblScope unit="pp">340-340</biblScope>
                  <date type="datePub">2025</date>
                </imprint>
              </monogr>
              <idno type="doi">10.3390/ph18030340</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <keywords scheme="author">
                <term xml:lang="en">Nystatin</term>
                <term xml:lang="en">Neomycin</term>
                <term xml:lang="en">Aerobic bacteria</term>
                <term xml:lang="en">Polymyxin B</term>
                <term xml:lang="en">Polymyxin</term>
              </keywords>
              <classCode scheme="halDomain" n="sdv.imm">Life Sciences [q-bio]/Immunology</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Background/Objectives: Aerobic vaginitis (AV) and bacterial vaginosis (BV) are vaginal infections requiring the fast elimination of pathogens. The frequent confusion of these infections may justify the use of a rapidly acting broad-spectrum antibiotic treatment. Methods: This study investigated the bactericidal kinetics of the neomycin-polymyxin B-nystatin (NPN) combination compared to those of two reference antibiotics (clindamycin and metronidazole) against 22 bacteria commonly implicated in AV and BV. Results: NPN exhibited bactericidal activity against the aerobic Gram-positive bacteria, with particularly high bactericidal activity being observed against streptococci, S. aureus, and C. amycolatum after 1 h at low dilutions and after 4 h for all dilutions. Enterococci were less sensitive to NPN. Clindamycin demonstrated poor rapid bactericidal activity against all Gram-positive bacteria tested. NPN manifested high bactericidal activity against all aerobic Gram-negative bacteria tested, whereas clindamycin showed bactericidal activity only after 4 h at a 1/2 dilution. With respect to the four anaerobic strains tested, NPN demonstrated high bactericidal activity at all tested dilutions with concentration-dependent effects. Metronidazole exhibited lower or no rapid bactericidal activity. Conclusions: These results suggest that NPN has very fast bactericidal action against the main bacteria involved in AV and BV compared to clindamycin and metronidazole, highlighting its potential in managing bacterial vaginal infections.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="institution" xml:id="struct-302908" status="VALID">
          <orgName>FONdation pour le DEveloppement de la REcherche PHARmaceutique - FONDEREPHAR (FRANCE)</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-448187" status="VALID">
          <idno type="IdRef">026388820</idno>
          <idno type="ISNI">0000000121766169</idno>
          <idno type="ROR">https://ror.org/033p9g875</idno>
          <orgName>Institut National Polytechnique (Toulouse)</orgName>
          <orgName type="acronym">Toulouse INP</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.inp-toulouse.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-443875" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-443875" status="VALID">
          <idno type="ROR">https://ror.org/017tgbk05</idno>
          <orgName>Communauté d'universités et établissements de Toulouse</orgName>
          <orgName type="acronym">Comue de Toulouse</orgName>
          <desc>
            <address>
              <addrLine>41 Allée Jules Guesde, 31000 Toulouse</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.univ-toulouse.fr/</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>